ty-1091
Showing 1 - 1 of 1
RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Chang chun
Not yet recruiting
- RET-altered Non Small Cell Lung Cancer
- +3 more
- TY-1091
-
Chang chun, Jilin, ChinaJinlin Province Cancer Hosipital
Dec 21, 2022